🎗️ OncologyInjection (IV)
Pluvicto
Lutetium Lu 177 Vipivotide Tetraxetan
PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.
Form
Injection (IV)
Uses
2
Side effects
5
Category
Oncology
01
What is Pluvicto used for?
- Metastatic castration-resistant prostate cancer (mCRPC)
- PSMA-positive prostate cancer
02
Lutetium Lu 177 Vipivotide Tetraxetan side effects
Common side effects of Lutetium Lu 177 Vipivotide Tetraxetan include:
Fatigue
Nausea
Dry mouth
Bone marrow suppression
Renal toxicity
CommonModerateLess common
03
Lutetium Lu 177 Vipivotide Tetraxetan warnings & precautions
- Myelosuppression. Monitor CBC
- Embryo-fetal toxicity
- Radiation safety precautions required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Pluvicto in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.